Journals

• Sparkes, E., Maloney, C., Markham, J., Dane, C., Boyd, R., Gilchrist, J., Moir, M., Gordon, R., Luo, J., Pike, E., Walker, K., Kassiou, M., McGregor, I., Kevin, R., Hibbs, D., Jorgensen, W., Banister, S., Cairns, E., Ametovski, A. (2024). Structure-Activity Relationships, Deuteration, and Fluorination of Synthetic Cannabinoid Receptor Agonists Related to AKB48, 5F-AKB-48, and AFUBIATA. ACS Chemical Neuroscience, 15(11), 2160-2181. [More Information]
• Sparkes, E., Santiago, M., Hibbs, D., Banister, S., Ametovski, A., Cairns, E., Markham, J., Boyd, R., Udoh, M., Gordon, R., Walker, K., Dane, C., Kevin, R., et al (2024). Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA. RSC Medicinal Chemistry, 15(6), 2063-2079. [More Information]
• Dane, C., Cumbers, G., Allen, B., Montgomery, A., Danon, J., Kassiou, M. (2024). Unlocking therapeutic potential: The role of adamantane in drug discovery. Australian Journal of Chemistry, 77(8), CH24075. [More Information]
• Dane, C., Stokes, L., Jorgensen, W. (2022). P2X receptor antagonists and their potential as therapeutics: a patent review (2010–2021). Expert Opinion on Therapeutic Patents, 32(7), 769-790. [More Information]